Cancer Research

In an era where personalized medicine is increasingly becoming the norm, microbiome science is emerging as a pivotal player in reshaping patient care. Understanding the intricate relationship between human health and the billions of microbes that inhabit our bodies presents a unique opportunity. By

Ivan Kairatov is a highly respected biopharma expert who has made significant contributions to the understanding and innovation in cancer research. With a focus on neuroblastoma, a particularly aggressive childhood cancer, his work is paving the way for new treatment strategies. In this interview,

In recent years, the intersection of biotechnology and plant biology has led to transformative developments in drug production, highlighting a pivotal turning point in the sustainable manufacturing of vital medicines. Among these advancements is the use of tobacco plants to synthesize baccatin III,

In a groundbreaking development poised to reshape medical diagnostics, Professor Kenji Suzuki and his team at the Institute of Science Tokyo have unveiled a pioneering AI model that has dramatically reduced data requirements for lung cancer diagnosis. Presented at the 2024 Annual Meeting of the

A critical patient is confronted with unsettling news: her colon cancer has returned despite rigorous chemotherapy treatment. Facing the daunting challenge of deciding the next steps, she wonders why there aren't more effective treatment options available. This poignant scenario echoes the broader

Ivan Kairatov's expertise in biopharma, particularly in advancing technologies and innovation within the industry, positions him as a leading figure in the field of biomedical imaging. With a wealth of experience in research and development, Ivan's contributions have greatly impacted the realm of